Headache Disorders, Primary
0
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Hua MedicineChina - Shanghai
2 programsChina Headache and Vertigo Registry StudyN/A1 trial
International Headache Registry StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Hua MedicineInternational Headache Registry Study
EppendorfElectric Current Stimulation
Hua MedicineChina Headache and Vertigo Registry Study
Clinical Trials (3)
Total enrollment: 210,036 patients across 3 trials
International Headache Registry Study
Start: Jul 2021Est. completion: Dec 2082200,000 patients
N/ARecruiting
Trigeminal Brainstem Mapping
Start: Jun 2019Est. completion: Sep 201936 patients
N/ACompleted
China Headache and Vertigo Registry Study
Start: Jun 2017Est. completion: Dec 205010,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 210,036 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.